-
2024-517423-40-00
5
2025-06-23
Metastatic Castration-Resistant Prostate Cancer
-
2024-519219-32-00
5
2025-06-23
Heart Failure With Reduced Ejection Fraction
-
2024-519284-18-00
5
2025-06-18
Relapsing multiple sclerosis
-
2024-513112-99-00
5
2025-06-13
Active Psoriatic Arthritis Stratified by Prior Biologic Use
-
2024-515764-31-00
10
2025-06-13
Non-small cell lung cancer
-
2023-505218-68-00
4
2025-06-12
Moderate-Severe Atopic Dermatitis
-
2023-510294-34-00
5
2025-06-12
small lymphocytic lymphoma (SLL)
-
2024-515698-85-00
5
2025-06-12
Locally Advanced or Metastatic Non-small Cell Lung Cancer
-
2023-510026-32-00
5
2025-06-11
Generalized Myasthenia Gravis
-
2024-513122-27-00
5
2025-06-10
Unresectable, Locally Advanced or Metastatic HER2 positive Gastric or
-
2024-512302-25-00
5
2025-06-06
Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
-
2024-517458-90-00
5
2025-06-06
Chronic obstructive pulmonary disease (COPD)
-
2024-517335-46-00
4
2025-06-05
Bladder cancer
-
2023-509391-42-00
11
2025-06-02
Chron's Disease
-
2024-517147-31-00
9
2025-05-23
Tumours, Gynecological
-
2024-517422-25-00
5
2025-05-22
Metastatic Castration-resistant Prostate Cancer (mCRPC)
-
2024-517513-32-00
5
2025-05-16
Sjögren’s Syndrome
-
2023-506327-29-00
5
2025-05-14
Non-Small Cell Lung Cancer
-
2024-513959-33-00
4
2025-05-13
Asthma
-
2023-506460-14-00
5
2025-05-07
Chronic kidney disease (CKD) and hypertension.
-
2024-514321-39-00
10
2025-05-06
Chemotherapy-induced nausea and vomiting
-
2023-509755-13-00
5
2025-04-28
Idiopathic steroid-sensitive nephrotic syndrome
-
2024-513053-69-00
5
2025-04-16
Moderately to Severely Active Crohn's Disease (CD)
-
2024-516363-92-00
5
2025-04-08
Psychosis Associated with Alzheimer’s Disease